-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 26037 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5400
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemammalian target of rapamycin-S2215Y
-
Alt namemTOR
-
SpeciesR. norvegicus (rat)
-
Insert Size (bp)7700
-
MutationS2215Y
-
Entrez GeneMtor (a.k.a. Frap1, RAFT1)
-
Tag
/ Fusion Protein
- AU1 (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Hind III (not destroyed)
- 3′ cloning site Not I (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer Sp6 (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3-AU1-mTOR-S2215Y was a gift from Fuyuhiko Tamanoi (Addgene plasmid # 26037 ; http://n2t.net/addgene:26037 ; RRID:Addgene_26037) -
For your References section:
Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer. Sato T, Nakashima A, Guo L, Coffman K, Tamanoi F. Oncogene. 2010 May 6. 29(18):2746-52. 10.1038/onc.2010.28 PubMed 20190810